OTCMKTS:CGYG

China Longyi Group International Stock Forecast, Price & News

$0.0001
0.00 (0.00 %)
(As of 02/24/2021)
Add
Compare
Today's Range
$0.00
Now: $0.00▼
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00▼
$0.00
VolumeN/A
Average Volume2,258 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
China Longyi Group International Holdings Ltd. operates as a holding company, which through its subsidiaries, Beijing SOD and Chongqing SOD, develops, manufactures, and markets superoxide dismutase (SOD) products. Its products include SOD Lifeblood, which is a mixture of SOD and enzymes as an antioxidant. The company was founded on February 29, 1996 and is headquartered in Beijing, China.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CGYG
Previous Symbol
CUSIPN/A
CIK1010566
Webwww.allsod.com
Phone861088452568
EmployeesN/A
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

MarketRank™

Overall MarketRank™

0.44 out of 5 stars

Medical Sector

1704th out of 2,024 stocks

Biotechnology Industry

102nd out of 147 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.0001
0.00 (0.00 %)
(As of 02/24/2021)
30 days | 90 days | 365 days | Advanced Chart

Receive CGYG News and Ratings via Email

Sign-up to receive the latest news and ratings for CGYG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











China Longyi Group International (OTCMKTS:CGYG) Frequently Asked Questions

What stocks does MarketBeat like better than China Longyi Group International?

Wall Street analysts have given China Longyi Group International a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but China Longyi Group International wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has China Longyi Group International's stock price been impacted by COVID-19?

China Longyi Group International's stock was trading at $0.0001 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CGYG stock has increased by 0.0% and is now trading at $0.0001.
View which stocks have been most impacted by COVID-19.

Who are China Longyi Group International's key executives?

China Longyi Group International's management team includes the following people:
  • Ms. Jie Chen, Chief Exec. Officer, Pres and Director (Age 62)
  • Mr. Xinmin Pan, Chief Financial Officer (Age 72)

Who are some of China Longyi Group International's key competitors?

Some companies that are related to China Longyi Group International include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), 17031 (MYM), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), ADiTx Therapeutics (ADTX), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF) and Almirall (LBTSF).
View all of CGYG's competitors.

What other stocks do shareholders of China Longyi Group International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other China Longyi Group International investors own include AVEO Pharmaceuticals (AVEO), Atossa Therapeutics (ATOS), Arrowhead Pharmaceuticals (ARWR), Arena Pharmaceuticals (ARNA), Aptose Biosciences (APTO), Ampliphi Biosciences (APHB), Applied DNA Sciences (APDN), Sphere 3D (ANY), Anthera Pharmaceuticals (ANTH) and Ampio Pharmaceuticals (AMPE).

What is China Longyi Group International's stock symbol?

China Longyi Group International trades on the OTCMKTS under the ticker symbol "CGYG."

How do I buy shares of China Longyi Group International?

Shares of CGYG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is China Longyi Group International's stock price today?

One share of CGYG stock can currently be purchased for approximately $0.00.

What is China Longyi Group International's official website?

The official website for China Longyi Group International is www.allsod.com.

Where are China Longyi Group International's headquarters?

China Longyi Group International is headquartered at 8A, 8/F East Area 69 Banjing Road, Haidian District Century Golden Resources Business Center, BEIJING, BEJ 100080, China.

How can I contact China Longyi Group International?

China Longyi Group International's mailing address is 8A, 8/F East Area 69 Banjing Road, Haidian District Century Golden Resources Business Center, BEIJING, BEJ 100080, China. The company can be reached via phone at 861088452568.


This page was last updated on 4/18/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.